“…8,9 The synthetic modifications reported thus far on the luotonin A core include principally alkyl and haloalkyl substituents on the A-ring; 10,11 aryl, 9f alkyl, 12 aminoalkyl, 12 and trifluoromethyl substituents on the Bring; 13 and halo, trifluoromethyl, and phenyl substituents on the E-ring. 14 In comparison to other rings, reports on modifications of the C-ring have been rather limited (i.e., C-ring methoxycarbonyl 15 and acetylamino 16 ). To address this, we set out (i) to develop facile access to C-ring-substituted luotonin A analogues to identify a potential lead for further optimization, and (ii) to extend the resulting methodology to structurally related alkaloids, such as 22-hydroxyacuminatine (6), 17 rutaecarpine (4), 18 rosettacin, 19 and evodiamine 20 (see Figure 1).…”